Integra LifeSciences
IART
IART
282 hedge funds and large institutions have $2.85B invested in Integra LifeSciences in 2023 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 88 increasing their positions, 110 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 110
32% less capital invested
Capital invested by funds: $4.18B → $2.85B (-$1.33B)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
282
Holding in Top 10
1
Calls
$3.46M
Puts
$2.48M
Top Buyers
| 1 | +$38M | |
| 2 | +$16.3M | |
| 3 | +$15.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.7M |
| 5 |
CC
Clearline Capital
New York
|
+$10M |
Top Sellers
| 1 | -$68.7M | |
| 2 | -$57.9M | |
| 3 | -$52.2M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$34.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$23.3M |